News for the Multiple Sclerosis Community

Clinical features of African- and Caucasian-Americans

"Factors that were similar in both AAs and CAs include:

  • Percentages of subjects with RRMS, PPMS, SPMS and PRMS
  • Percentages of females vs. males
  • Distribution of probable lesion sites at onset
  • Occurrence of optic neuritis

    Areas where there were differences include:

  • Age at onset of first symptoms (AAs were on average 2.6 years older)
  • Time from onset to diagnosis and from onset to treatment (shorter for AAs)
  • Disability rate as measured by time to needing a cane or wheelchair (shorter time in both cases for AAs)
  • Prevalence of opticospinal MS, where symptoms are restricted to the optic nerve and spinal cord (higher in AAs)
  • Occurrence of transverse myelitis, in which there is partial bilateral paralysis, and sensory and sphincter impairment (higher in AAs)

    Overall, the results revealed that African-Americans tend to have a more severe disease course and are more likely to have the opticospinal form of MS and transverse myelitis. The increase in severity may be partially explained by the later age at onset, which has been associated with faster progression in other studies. The authors discussed whether differences in medical care could also help account for the differences in disability progression. They note that all participants were followed by neurologists and that AAs were equally likely to receive MS disease-modifying drugs as CAs, but also pointed out that there were differences between the groups in treatment duration and numbers of different treatments given. The authors also mention that genetic studies are being carried out to assess the influence on MS risk from genetic variants that are African or Caucasian in origin. It may also be that these studies could indicate genes that influence clinical features of MS, such as those that were found in this study."